FluroTech Expands nanoComposix Mandate; Initiating Covid-19 Test Performance Evaluation and Validation
FLURF) (“FluroTech” or the “Company”), is pleased to announce that, FluroTest Ltd. (“FluroTest”) has retained San Diego-based nanoComposix, a leading life sciences nanotechnology company that specializes in R&D and manufacturing of lateral flow rapid tests, to immediately begin lab performance studies for FluroTest’s rapid antigen testing pandemic defense platform. This move builds upon previously announced and ongoing optimization efforts, bringing FluroTest one step closer to su...
Steve Oldenburg William Phelan Danny Dalla Mauricio Arias Corporation Annual Information Form Drug Administration For Emergency Use Authorization
Source: financialpost.com